Erythema infectiosum

Published on 05/03/2015 by admin

Filed under Dermatology

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1286 times

83

Erythema infectiosum

DDx Ref       208284

image

Facial erythema ‘slapped cheek’ is characteristic of erythema infectiosum. Note sparing of the nasolabial folds and perioral regions.

image

‘Fish net’ lacy erythema occurs 2 days after the facial erythema on the extensor surface of the arms.

image

This highly characteristic lacy red net-like pattern last from a few days to 3 weeks. It may recur over several weeks.

image

Lesions can appear as round, faint pink–orange plaques with central clearing.

DESCRIPTION

Common viral exanthem produces bright-red cheeks and lacy erythema of arms. Caused by parvovirus B19. Also called fifth disease or slapped cheek syndrome.

HISTORY

• More prevalent in winter and spring; most common in children 5–14 years old; community outbreaks; transmitted via respiratory secretions, blood, or vertically from mother to fetus. • Asymptomatic infection common. • Latent period 4–14 days. • Arthralgias in adults. • When rash appears, not considered infectious. • Self-limited in most patients.

PHYSICAL FINDINGS

• Facial erythema gives slapped cheek appearance. Warm, symmetric, erysipelas-like plaques on cheeks, sparing nasolabial folds and circumoral region (circumoral pallor). Fades in 4 days. • Two days after facial rash onset, a lacy erythema occurs on proximal extremities, extending to trunk and buttocks. Fades in 6–14 days. • Sunlight, hot water, physical and emotional exertion exacerbate the rash. • Adult women can develop arthritis or small joints of hands and knees, similar to rheumatoid arthritis; lasts 2–4 weeks. Arthritis usually resolves in less than 4 months but may be chronic. Men usually do not develop arthritis. • In adults, rash can be non-specific macular eruption or acrally located (stocking and glove distribution). • Infection during pregnancy: risk of fetal loss is 8–10%, greatest if infection before 20 weeks’ gestation.

TREATMENT

Non-steroidal antiinflammatory drugs for joint symptoms for most patients. No treatment required for rash.